81 related articles for article (PubMed ID: 32243310)
1. A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.
Clarke MA; Unger ER; Zuna R; Nelson E; Darragh TM; Cremer M; Stockdale CK; Einstein MH; Wentzensen N
J Low Genit Tract Dis; 2020 Apr; 24(2):148-156. PubMed ID: 32243310
[TBL] [Abstract][Full Text] [Related]
2. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
3. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
4. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
Demarco M; Cheung LC; Kinney WK; Wentzensen N; Lorey TS; Fetterman B; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2018 Apr; 22(2):97-103. PubMed ID: 29570564
[TBL] [Abstract][Full Text] [Related]
5. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
6. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
[TBL] [Abstract][Full Text] [Related]
7. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
9. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
10. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of using a self-lavaging device for cytology and HPV testing for cervical cancer screening: findings from a pilot study.
Jones HE; Mansukhani MM; Tong GX; Westhoff CL
PLoS One; 2013; 8(12):e82115. PubMed ID: 24376516
[TBL] [Abstract][Full Text] [Related]
13. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Schiffman M; Wentzensen N; Perkins RB; Guido RS
J Low Genit Tract Dis; 2020 Apr; 24(2):87-89. PubMed ID: 32243305
[No Abstract] [Full Text] [Related]
14. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum.
J Low Genit Tract Dis; 2020 Oct; 24(4):427. PubMed ID: 32732649
[No Abstract] [Full Text] [Related]
15. The mystery of posttreatment cancer surveillance.
Cho CS
Cancer; 2023 Feb; 129(4):503-504. PubMed ID: 36541013
[No Abstract] [Full Text] [Related]
16. Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management.
Clarke MA; Darragh TM; Nelson E; Unger ER; Zuna R; Cremer M; Stockdale CK; Einstein MH; Wentzensen N
J Low Genit Tract Dis; 2020 Apr; 24(2):157-166. PubMed ID: 32243311
[TBL] [Abstract][Full Text] [Related]
17. Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection.
Bruno MT; Scalia G; Cassaro N; Costanzo M; Boemi S
BMC Infect Dis; 2020 Oct; 20(1):801. PubMed ID: 33121447
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia.
Zang L; Huang J; Zhu J; Hu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():175-181. PubMed ID: 34689015
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]